Biomet acquires assets of Cytosol Laboratories - MarketLine Financial Deals

Biomet acquires assets of Cytosol Laboratories

Biomet acquires assets of Cytosol Laboratories - MarketLine Financial Deals
Biomet acquires assets of Cytosol Laboratories
Published Jul 16, 2010
2 pages — Published Jul 16, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Biomet, Inc., a manufacturer of musculoskeletal medical products, has acquired all of the assets of Cytosol Laboratories.

  
Source:
Document ID
MA29091_100721
Country
Ticker
BMET=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Biomet acquires assets of Cytosol Laboratories" Jul 16, 2010. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Biomet-acquires-assets-of-Cytosol-Laboratories-2052-37446>
  
APA:
MarketLine Financial Deals. (2010). Biomet acquires assets of Cytosol Laboratories Jul 16, 2010. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Biomet-acquires-assets-of-Cytosol-Laboratories-2052-37446>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.